Inventor · disambiguated record
Ramon Mohanlal
Also filed as: MOHANLAL RAMON · MOHANLAL RAMON W
9 granted patents·9 pending applications·45 citations·filing 2001–2024
85Inventor score
Top patents by PatentIndex Score
18 records- 0192US11229642B2Composition and method for reducing neutropeniaBEYONDSPRING PHARMACEUTICALS INC·Filed 2017·Granted Jan 25, 2022·6 cites·25 claims
- 0292US10912748B2Compositions containing tucaresol or its analogsBEYONDSPRING PHARMACEUTICALS INC·Filed 2017·Granted Feb 9, 2021·8 cites·18 claims
- 0391US11857522B2Compositions containing tucaresol or its analogsBEYONDSPRING PHARMACEUTICALS INC·Filed 2021·Granted Jan 2, 2024·2 cites·26 claims
- 0488US11786523B2Composition and method for reducing thrombocytopeniaBEYONDSPRING PHARMACEUTICALS INC·Filed 2019·Granted Oct 17, 2023·3 cites·31 claims
- 0586US11400086B2Method of reducing chemotherapy-induced neutropeniaBEYONDSPRING PHARMACEUTICALS INC·Filed 2018·Granted Aug 2, 2022·5 cites·19 claims
- 0682US7198895B2In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicalsMOHANLAL RAMON W·Filed 2001·Granted Apr 3, 2007·21 cites·10 claims
- 0780US12377094B2Therapeutic compositions and methods for treating checkpoint inhibitor-resistant tumors using plinabulin-based combination therapiesBEYONDSPRING PHARMACEUTICALS INC·Filed 2024·Granted Aug 5, 2025·0 cites·22 claims
- 0875US12458638B2Method of stimulating neutrophil survival and reducing neutropeniaBEYONDSPRING PHARMACEUTICALS INC·Filed 2022·Granted Nov 4, 2025·0 cites·21 claims
- 0967US12433886B2Composition and method for reducing neutropeniaBEYONDSPRING PHARMACEUTICALS INC·Filed 2022·Granted Oct 7, 2025·0 cites·19 claims
- 1065US2024197723A1Therapeutic compositions and methods for treating tumorsBEYONDSPRING PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1158US2024408082A1Methods for treating cancers and tumorsBEYONDSPRING PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1257US2007166754A1In Vitro Cell-based Methods for Biological Validation and Pharmacological Screening of Chemical Entities and BiologicalsMOHANLAL RAMON W·Filed 2007·Application pending·0 cites
- 1355US2023181605A1Triple combination therapy for enhancing cancer cell killing in cancers with low immunogenicityBEYONDSPRING PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1452US2024299377A1Methods and compositions for treating iron disordersBEYONDSPRING PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1551US2021177952A1Method and composition for stimulating immune responseBEYONDSPRING PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1644US2021030843A1Composition and method for reducing chemotherapy-induced neutropenia via the administration of plinabulin and a g-csf agentBEYONDSPRING PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1743US2020129504A1Compositions of plinabulin and use thereofBEYONDSPRING PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1840US2007225339A1Compositions and methods for treating rheumatoid arthritisMOHANLAL RAMON·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ramon Mohanlal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →